Abstract. Integrin Associated Protein (LAP) is a 50-kD membrane protein which copurifies with the integrin a4~3 from placenta and coimmunoprecipitates with 153 from platelets. IAP also is functionally associated with signal transduction from the Leukocyte Response Integrin. Using tryptic peptide sequence, human and murine IAP cDNAs have been isolated. The protein has an extracellular amino-terminal immunoglobulin domain that binds all monoclonal anti-LAP antibodies. The carboxy-terminal region is highly hydrophobic with three or five membrane-spanning segments and a short hydrophilic tail. Immunofluorescence microscopy suggests that this hydrophilic tail is located on the inside of the cytoplasmic membrane. Monoclonal anti-IAP antibody inhibits the binding of vitronectin-coated beads to c~vfl3 on human erythroleukemia cells, and polyclonal anti-IAP recognizes hamster LAP on CHO cells and inhibits vitronectin bead binding. When CHO cells are transfected with human LAP, monoclonal anti-human antibody completely inhibits vitronectin bead binding. These data suggest a model in which ligand binding by otv~3 is regulated by IAE HESION receptors of the integrin family recognize several proteins of the extracellular matrix and appear to be critical for the induction of normal morphology and migration of many cell types (2, 4, 6, 22, 31) . While the interaction of integrins with their ligands has been the subject of intense study over the past several years, much less information has been gathered about the molecular mechanisms by which integrins affect cell phenotype and function. Recently, we described a cell surface protein which we copurified with the integrin avfl3 from placenta and which also coimmunoprecipitated with f13 integrins from platelets (5). This coprecipitating protein had a Mr of ~50 kD on SDS-PAGE, was highly hydrophobic, and was widely expressed. The 50-kD protein itself did not recognize the Arg-Gly-Asp peptides with which ot453 was purified (5), but mAb recognizing the 50-kD protein could inhibit several neutrophil and monocyte functions mediated by a leukocyte fl3-1ike integrin, including ligand binding (5, 16, 17, 35) . Therefore, we hypothesized that the 50-kD protein, which we called Integrin-associated Protein (IAP), ~ could physically associate with some integrins and, without directly binding the integrin ligands, could regulate integrin function. Now, we have cloned IAP eDNA from both human and mouse cells and examined its structure and role in binding vitronectin (Vn) ligand in native and transfected cells.
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Materials and Methods

Tissue Culture
Tissue culture cells were grown at 37°C, 5% CO2, in Iscove's Modified Dulbecco's Medium (GIBCO BRL, Gaithersburg, MD), supplemented with 10% FCS (Hyclone Labs., Logan, UT). For bead binding, CHO cells were grown in Ham's F12 with 10% FCS supplemented with 250 #g/ml active G418.
Antibodies
The mouse IgG1 anti-IAP mAbs used have been described previously (5, 16) . B6H12, 1F7, 2B7, 2Ell, and 3E9 are inhibitory to Leucocyte Response Please address all correspondence to Dr. Eric Brown, Campus Box 8051, Washington University School of Medicine, 660 S. Euclid Avenue, St. Louis, MO 63110.
Integrin (LRI)-stimulation of Fc-receptor-mediated phngocytosis in neutrophils. 2D3 and 3G3 are non-inhibitory. All antibodies immunoprecipitate IAP. mAh 6F2 is an isotype matched control.
Preparation of Anti-Peptide Antibodies
A peptide, CNQKTIQPPRNN, was synthesized by the Washington University Protein Chemistry facility. This peptide corresponds to the carboxyterminal II amino acids predicted by ptAP3, with an amino-terminal cysteine added for conjugation to keyhole limpet hemocyanin. Cross-linking was performed using the bifunctional cross-linker bromacetylsuccinimidc, as previously described (16) . Rabbits were immunized with 50 fig of the protcin-peptide conjugate in complete Freund's adjuvant, and then 20 d later in incomplete Freund's adjuvant. Immunization in incomplete Freund's was continued on a monthly basis for 2 mo.
mAbs against the human tAP carboxy terminus were prepared as described (16) using 50 ~tg of the peptide conjugate per injection. The two mAbs used in this study both immunoprecipitate human tAP and hind to the human carboxy-terminal peptide. Miapl51 also reacts with the corresponding peptide derived from the mouse sequence, whereas miapl31 does not, demonstrating that the two mAbs have different antigen combining sites.
IAP Cloning
Standard techniques were used for cloning and other nucleic acid manipulation (32) . A tryptic peptide sequence, VEFTFCNDTVVIPCFVTNMEAQ, was obtained from tAP purified from placenta, as previously described (5) . Based on this sequence, two degenerate oligonucleotides were synthesized and used for PCR using a U937 CDNA library in ~,tl0 (the kind gift of Dr. Douglas Lublin, Washington University) as template. The forward oligonucleotide was 5'-GTIGA(ag)TT(te)ACITT(te)TG(te)AA(te)GA-3', and the inverse was 5'-TGIGC(TC)TCCAT(ng)TTIGTIAC(ng)AA(ag)CA-3'. The PCR product of 66 bp was cloned into pBinescriptlI-KS(+) (Stratagene, La Jolla, CA), sequenced (33) to confirm that it encoded the expected peptide, and used to probe the U937 cDNA library using conventional techniques. The EcoRI insert was subcloned from the phage into pBhiescriptII-KS(+) resulting in pIAP0. A 5'-fragment (EcoRI-Xmnl) of the ptAP0 insert was used to screen a )~ZAPII (Stratagene) cDNA library from differentiated HL60 cells (the kind gift of Dr. Brian Volpp, University of Iowa), from which several clones containing the entire coding sequence were obtained. Two clones, ptAP3 and ptAP4, were sequenced to obtain unambiguous overlapping readings from both strands. Plasmid ptAP4 contains tAP with the longest 5' untranslated sequence, but the plasmid also contains a second unrelated cDNA. Therefore, ptAP3 was used for all further studies. Several other clones were sequenced on one strand or partially. These clones varied in the length of their 5' and 3' untranslated sequences, but were identical to ptAP3 in the coding region to the extent of the sequence obtained. The sequence submitted to Genhank ( Fig. 1 ; Accession number 7_25521) is the synthesis of the sequences obtained from pIAP3 and ptAP4. Pinsmid pIAP0 has a 32 bp deletion ( Fig. 1 ) compared to ptAP3/ptAP4 at the 3' end of the coding sequence, presumably due to alternative splicing.
Murine tAP cDNA was obtained by screening a cDNA library from the 70Z/3 pre-B cell line using the full length human tAP cDNA under conditions of intermediate stringency. One of the initial clones, ptAP28, was used for further study. The library was rescreened with a 5' murine IAP probe to obtain clones with as much 5' untranslated sequence as possible. The 5' end of the clone with the longest 5' untranslated sequence, pIAP42, was sequenced. The 5' untranslated region of ptAP28 was identical to the corresponding region of ptAP42. The sequence submitted to Genbank (accession number Z25524) is the synthesis of the sequence obtained from ptAP28 and pIAP42.
Sequence Analysis
The National Center of Biotechnology Information (NCBI) electronic mail servers BLAST (25) and RETRIEVE were used to find and retrieve homologous sequences. Sequence comparison was done by the Needleman and Wunsch algorithm (10) with the protein alignment matrix PAM250, a bias of 10, and a gap penalty of 10. The result for a pair of sequences was given as standard deviations of the score above the mean of the alignment score for 150 random permutations of the same sequences. Hydrophobicity plots were calculated as described by Kyte and Doolittle (39) using a window of 11 residues.
Construction of lAP Expression Plasmids and
Chimeric IAP Genes ptAP3 was digested with HindlII and Xbal, which cut in the pBluescriptII-SK(-) polylinker just 5' and 3' of the insert, respectively. The resulting HindIII-XbaI fragment was ligated into pRC/RSV (Invitrogen, La Jolla, CA) digested with the same enzymes, yielding ptAP45, tAP was divided into three regions, delimited by stretches of amino acid sequence identity between the human and mouse variants. The delimiting sequences were chosen so that unique restriction sites could be introduced into the cDNAs, without altering the amino acid sequence. Using PCR, the gene segments were obtained individually, subcloned, and sequenced. Fig. 1 shows the doubly underlined regions of homology between the oligonucleotides used and the human IAP cDNA sequence. The letters labeling the regions are placed under the amino acids delimiting the segments. The corresponding point in the mouse sequence can be deduced from the alignment in Fig. 2 . The 5' hydrophobic segment encoding region (amino acids MI-S Is) was obtained as an )~aI-BamHI fragment (oligonucleotides 5'-GAAG TC~ CC ATG TGG CCC CTG GTA GCG-3' and 5'-TAG CTG AGC GGATCC GCA GCA GC-3' for human tAP, and 5'-GAAG TCTAGA CC ATG TGG CCC TTG GCG GCG-3' and 5'oTAG TTG AGC GC~TCC GCA GCA GC-3' for mouse tAP; Fig 1. segment a-b) . The DNA encoding the hydrophilic domain (S18-wl36) was obtained as a BamHI-PvulI fragment 
FACScan and FACSorting
Fluorescent flow microcytometry was performed using anti-human tAP mAbs precisely as described (5) . Before incubation with anti-IAP mAbs, CHO cells were removed from tissue culture plates by incubation with trypsin-EDTA and washed twice with PBS. For FACSortlng, cells were removed from the plates using Dulbecco's PBS with 2 mM EDTA, stained, resuspended to 5 × 106 cells/ml, and sorted in an Epics 753 FACSorter. Generally, the 5 % most fluorescent cells were recovered.
Transfection of CHO Cells
CHO cells were grown to 50% confluence in 35-ram diam dishes and transfected with 3/tg plasmid DNA using the calcium phosphate method (15) . Cells were grown for 24 h in nonselective medium. They were then removed with trypsin-EDTA and seeded into 25 cm 2 flasks containing medium with 600 t~g/ml active CJ418 (GIBCO BRL). After 14 d, the pool of survivors was analyzed by FACScan. For subsequent experiments, enrichment for expressors was carried outby FACSorting the 5% highest staining cells using an anti-IAP mAb (1F7) as primary antibody. Anti-sense and vector control transfectants were sorted similarly.
for immunoprecipitation. 1 #1 of rabbit serum was incubated with 20 #1 protein A-Sepharose (Pharmacia LKB Biotechnology, Piscataway, NJ) or 100 #1 of monoclonal antibody tissue culture supernatant was incubated with 20 #1 anti-mouse IgG-Sepharose (Cappel Organon-Technica, West Chester, PA). The antibody-charged Sepharose was washed and added to 200 #1 of cell lysate, incubated for 2 h to overnight at 4°C, washed twice with lysis buffer, and twice with PBS containing 0.05 % Tween-20. The Sepharose pellet was heated to 65°C for l0 rain in Laemmli buffer for SDS-PAGE (9), the sample electrophoresed through a 10% SDS-PAGE gel and transferred to polyvinylidine difluoride paper (Milipore, Bedford, MA). Immunoprecipitated proteins were detected using streptavidin conjugated to horseradish peroxidase (Jansen Biochimica, Belgium) and chemiluminescence peroxidase substrate (ECL, Amersham Corp., Arlington Heights, IL).
In Vitro Translation
Wild-type and mutant lAP cDNAs were cloned into pBluescriptlI-KS(+) under the control of the phage T7-promoter. The plasmids were linearized at the 3'-end of lAP and in vitro transcribed by TT-RNA polymerase in the presence of 500 #M mTG(53ppp(53G cap analogue (New England Biolabs, Beverly, MA). The RNA was in vitro translated using rabbit reticulocyte lysate in the presence of [3SS]methionine (Amersham Corp.), and canine pancreatic microsomal membranes for cotranslational processing (Promega Corp., Madison, WI), according to the manufacturer's instructions. In vitro translated products were immunoprecipitated with various anti-lAP mAb or an isotype matched irrelevant control, as described above. Supernatants of negative immunoprecipitations were analyzed by SDS-PAGE to confirm the presence of an appropriate size in vitro translation product.
Preparation of Vitronectin-coated Beads
Ligand-coated beads were prepared by incubating 4 × 10 s 1.3 /zm aldehyde-modified fluorescent latex beads (Molecular Probes, Eugene, OR) with 10/zg purified Vn (Telios Pharmaceuticals, San Diego, CA), fibronectin (Fn, Telios), or human serum albumin (HSA) as a control in 200 ~1 of PBS. After 1 h at 37°C, 10 mg of HSA in 800 ~1 PBS was added to quench unreacted sites. After 1 h the beads were washed and resuspended in 1 nd of HBSS containing divalent cations (see below) and 1% HSA. Immediately before use, the preparations were soaicated for 1-2 s to disrupt aggregates.
Vitronectin-bead Binding
Vn-bead and Fn-bead binding to human erythroleukemia (HEL) cells was assessed by a modification of the previously described assay (17) . The standard incubation mixture contained 1.5 x 10 ~ cells, various concentrations of antibodies, and 45 #1 of ligand-coated beads in a volume of 130 #1. The incubation buffer for Vn-beads was HBSS with 1% HSA, 2 mM CaC12, 1 mM MgCI2, and 1 mM MnCI2. The incubation buffer for Fn-beads was identical except for omission of the CaCI2 and MgC12. These divalent cation conditions allowed maximal binding of Vn-beads to uJ~3 and Fn-beads to ~5/31 without interaction with other cell surface receptors. For antibody inhibition studies, ceils were incubated with various monoclonal and polyclonal antibodies for 15 rain at room temperature and for 15 rain before the addition of the beads. The antibodies used were rabbit nonimmune IgG (18 #g); rabbit anti-VnR (16) 1:100; rabbit IgG anti-lAP (18 t~g); rabbit anti-FnR (Telios) 1:100; murine IgG1 anti-lAP mAb 2D3 (22 t~g); murine IgG/antilAP mAb B6H12 (22/zg); murine IgG1 anti-153 mAb 7G2 (25 #g); and murine anti-as IgG3 mAb P1D6 (Telios, 1:100). After 1 h at 37°C, the cells were washed three times in PBS and the number of beads bound assessed by microscopy. Binding was quantitated as an attachment index (AI), the number of beads bound per 100 cells.
Binding experiments with CHO transfectants were performed essentially identically, except that 2 x 104 CHO cells were adhered to glass 4-chamber LabTek slides (Nunc Inc., Naperville, IL) overnight and used as adherent cells. The total volume of the reaction mixture in the LabTek chamber was 500 ~1, and antibody additions were increased to keep the concentration similar to that used for the HEL ceils in suspension.
Results
Cloning of lAP
To determine the structure of IAP, we cloned its cDNA from a U937 3~rtl0 cDNA library (27) . Several cDNAs were ana- 
TTCATGGTTTT CT CCAAATGAAAATATTC TTATTGTTATTT TC C CAATTTTTGC TATAC T 461
CATT CTTTTCGTCC CAGGTGAATATT CATTA~GAATGC TAC TGGCC TTGGT TTAATTGT 641 identical to lAP in terms of size and antibody reactivity (see below). The 3' end of the coding region of the U937 clone had a 3 ~o deletion (singly underlined in Fig. 1 ) compared to the I-]Lt~ :DNAs, which leads to premature termination of the protein at Glu 293. This form also constitutes a very small minority of the clones obtained from the HL60 library. It presumably arose from alternative splicing of lAP mRNA, since both the sequence in the coding region 5' to the deletion and the 3' untranslated sequence of this cDNA are identical to those of the longer HL60 cDNAs. Further evidence that the cDNAs encoded IAP was obtained by induction of anti-human IAP rnAb reactivity with CHO cells after transfection with IAP cDNA (Fig. 3) . This was confirmed by immunoprecipitation of an appropriate Mr band on SDS-PAGE from the transfected CHO with anti-lAP mAb (Fig. 4 A) . Immunoprecipitations were done in 1% Triton X-100 and 1% deoxycholate, conditions under which integrin coimmunoprecipitation is not seen. To finally prove that the cDNA encoded lAP, we prepared an antibody L i n d b e r g et al. Cloning oflntegrin-associated Protein by immunizing rabbits with a synthetic peptide made from the predicted sequence of the lAP eDNA. This peptide, NQKTIQPPRNN, was the earboxy-terminal 11 amino acids of the sequence of the most common form of lAP eDNA in the HL60 library, which encoded the longer open reading frame. This anti-peptide antibody was used in sequential immunoprecipitation with 1F7, a previously characterized anti-lAP mAb (5) . Under the conditions of cell lysis and immunoprecipitation, lAP migrates as a 50-kD protein on Superose 12 chromatography (data not shown), which is the size of the monomeric protein on SDS-PAGE. As shown in Fig. 4 B, antibody against the predicted sequence completely precleared all 1F7-immunoprecipitable lAP antigen from human platelets. Thus, the lAP cDNA encodes tryptic peptides of placental IAE confers reactivity with all anti-lAP mAb on CHO cells, and antibody made against a peptide sequence predicted by the eDNA is able to recognize native lAP in platelets. Thus, the eDNA encodes IAE Murine IAP was cloned from a 70Z/3 pre-B cell eDNA library by homology to human lAP. Its predicted amino acid sequence is 71% identical and 87% similar to human lAP (Fig. 2) . There is a 2-amino acid deletion and a 21-amino acid insertion in murine IAP relative to the human protein.
The predicted carboxy terminus of murine lAP shows identity at 9 of 11 amino acids, and the polyelonal anti-peptide antibody made against the predicted human sequence immunoprecipitated a 48-kD protein from surface-labeled murine platelets, erythrocytes, and splenocytes (data not shown). Thus, the murine eDNA, like the human, encodes a widely expressed plasma membrane protein.
lAP Is Homologous to Poxvirus Proteins and Contains an Immunoglobulin Domain
When the lAP protein sequence was compared to Genbank sequences, human IAP was found to be identical to a recently cloned ovarian carcinoma antigen recognized by the mAb OVTL3 (7). The sole difference found was the absence in the OVTL-3 5' untranslated sequence of the guanidine at position -85 of the human IAP cDNA sequence (Fig. 1) . IAP is highly homologous to open reading frame A38L of the Vaeeinia (alignment scores of 8.6 and 7.8 with human and murine IAP, respectively) and Variola major virus genomes ( Fig. 2; top) (1, 12) .
Kyte-Doolittle (39) hydrophobicity analysis (Fig. 5) indicates that lAP and A38L can be divided into a hydrophilie amino-terminal half and a hydrophobie earboxy-terminal domain. There is also an amino-terminal hydrophobie sequence which has the features of a signal peptide. Whether the amino terminus of lAP forms a transmembrane domain or is a signal sequence is currently unknown since the amino terminus of lAP purified from placenta, erythrocytes, and HL60, is blocked. The highly homologous A38L proteins have too few amino acids at their amino termini to form a membrane-spanning domain but these amino termini likely encode signal peptides. By analogy, the 20 amino acids at the amino terminus of lAP are likely to form a signal peptide. The blocked amino terminus of mature lAP may well begin with a pyrollidone earboxylie acid at Q19.
The hydrophilie sequence after the putative signal peptide has three cysteines. The regions around the second and third of these show homology to the corresponding regions of several proteins in members the immunoglobulin superfamily. Further comparison shows that the amino terminus of IAP is most related to the IgV family, with significant homology to multiple family members (Table I ; Fig. 2 ; bottom).
Anti-IAP mAbs Recognize the IgV-like Domain
Previous work has functionally characterized multiple anti-IAP mAb and demonstrated at least three distinct antigenic extracellular epitopes by crossinhibition and immunofluorescence studies (5). Therefore, we investigated which IAP domains are recognized by these various mAbs. Chimeric cDNAs were constructed which encoded hybrid proteins with the human immunoglobulin-like loop and murine transmembrane domain and the inverse construct encoding a murine immunoglobulin-like loop with human transmembrane domains. These chimeric constructs were transcribed and translated in vitro, and the translated products immunoprecipitated with anti-human lAP mAbs. As shown in Fig. 6 , all seven anti-human mAb recognized proteins containing the human IgV-like domain, regardless of whether the rest of the molecule was murine or human sequence. The data were confirmed by FACS analysis of stable CHO transfeetants expressing the same chimeric eDNA constructs (data not shown). These results demonstrate that this large hydrophilic domain is indeed extracellular.
lAP Membrane-spanning Segments
The carboxy-terminal hydrophobie regions of both IAP and the A38L proteins have five potential membrane-spanning segments ( Fig. 5 and Fig. 2, top) . Sequences were aligned using the Needleman and Wunsch algorithm (10) Fig. 2; top) and the relative hydrophobicity of the region between segments 4 and 5, make the assignment of segment 4 more tentative. This segment alone or together with segment 5 could be a membrane-associated rather than membrane-spanning region.
Immunolocalization of the l A P Carboxy Terminus
Since the total number of membrane-spanning segments after the IgV domain would affect the localization of the carboxy-terminal hydrophilic peptide, we decided to determine whether the carboxy terminus is located on the inside or outside of the cytoplasmic membrane. Human T24 uroepithelial carcinoma cells were stained with or without prior permeabilization with methanol with mouse mAbs miapl31 and miapl51 against the human lAP carboxy terminus (see Materials and Methods). As controls, 2D3 binding to extracellular parts of IAP and negative antibody 6F2 were used. As shown in Fig. 7 , both miapl31 and miapl51 stain T24 cells only after methanol permeabilization, suggesting that the carboxy terminus is located in the cytoplasm. This in turn implies that the carboxy-terminal hydrophobic domain of IAP must encode an odd number of membranespanning segments.
Structural Model for lAP
From this information a structural model of lAP was made (Fig. 8) . This model predicts a protein with an amino-terminal IgV-like extracellular domain and a carboxy-terminal multiply membrane-spanning domain. The IgV-like domain contains all but one predicted N-glycosylation sites. At least four of these sites are used, since amino acid sequencing of tryptic peptides from IAP purified from placenta gave very low yields at the predicted Asn. The IgV homology suggests the disulfide linkage shown in Fig. 8 , although its presence has not been shown experimentally. Since the IgV-like domain is extracellular and the carboxy terminus intracellular, the carboxy-terminal hydrophobic domain has an odd number of membrane-spanning segments. The hydropathy plot of this region is consistent with 5 transmembrane domains as shown. However, the assignment of segment 4 (third transmembrane segment in Fig. 8 ) is more tentative due to the lack of a basic phospholipid anchoring amino acid and the presence of a histidine near the center of the segment. If segment 4 is not membrane spanning, this would have to be true also of segment 3 or 5. The strongly hydrophobic character of these regions of lAP suggest that they would be membraneassociated if not membrane-spanning.
Anti-lAP Inhibits a,/3r~lependent Ligand Binding
IAP is a widely expressed protein, present on many cell types and was initially copurified with OLv133 from placenta. Anti-IAP antibodies inhibit binding of multivalent RGD-and KGAGDV-peptides to polymorphonuclear cells (PMN) (16, 17) , but careful study of the functional effect of these antibodies has been limited to this genetically nonmanipulatable system. To determine whether anti-lAP mAb might affect O~v133 function, we examined the binding of Vn-and Fncoated beads to HEL cells, which are known to express OevJ33 and ~sfl~. Anti-IAP mAb B6H12, which inhibits ligand bead binding to PMN (16) , inhibited the binding of Vn-beads but not Fn-beads to these cells (Fig. 9 ). Anti-IAP mAb 2D3, which does not inhibit ligand-bead binding to PMN, also did not inhibit Vn-bead binding to HEL cells. Binding of Vn-beads was inhibited both by polyclonal antic~v/33 and by the anti-/33 mAb 7G2. These data demonstrate that anti-lAP mAb can inhibit Vn binding to o~vfl3, but does not affect Fn binding to ot5/3~ on the same cells.
Anti-Human lAP mAb Inhibit Vitronectin Receptor Function in Transfected CHO Cells
We used the ability of anti-lAP to inhibit Vn binding to av integrin receptors to examine the function of transfected human IAP in CHO cells, using mAbs that recognized only the transfected human molecule. In these cells transfected with IAP eDNA, half or less of the total expressed LAP was human, as judged by alteration in binding of polyclonal anti-IAP (Fig. 10 A) . Polyclonal anti-human lAP recognized hamster IAP (Fig. 10 A) and inhibited binding of Vn-beads to untransfected CHO cells and CHO cells transfected with the control reverse eDNA (Fig. 10 B) . 
Discussion
We have previously described a 50-kD protein which copurifled with olv~3 from placenta and which coimmunoprecipitared with/~3 integrins from platelets. Because of this, we called this protein the Integrin Associated Protein, IAP. Now, we have cloned IAP cDNA. The proof that the cloned molecule is IAP is that (a) several tryptic peptides derived from native placental IAP are found in the predicted amino acid sequence of the clone; (b) the product of in vitro transcription/translation of the cloned cDNA is recognized by all anti-IAP mAb; (c) transfection of the human cDNA into CHO cells confers reactivity with mAb specific for human IAP on the transfectants; and (d) immunoprecipitation with a cDNA sequence derived carboxy-terminal peptide antibody preclears all lAP reactivity from a platelet lysate. The predicted amino acid sequence of the cDNA is highly hydrophobic and predicts a molecule with a single extraceUular IgV-like domain and multiple membrane-spanning segments. Because immunoglobulin domains are often involved in intermolecular interactions, this structure suggests the hypothesis that the extracellular domain is important in the interaction of lAP with its associated integrins. The relative lack of conservation of the extracellular domain between mouse and human lAP (61% compared to 77% in the multiple transmembrane domains) is still consistent with this hypothesis, since the amino acid sequence of ICAM-1, another immunoglobulin superfamily molecule which interacts with integrins, is even less conserved between these species (20) . The sequence of IAP is identical to the sequence of a recently cloned ovarian carcinoma antigen (7). This antigen was cloned because it was recognized by an "ovarian carcinoma-specific" antibody, OVTL3 (3, 29) . We cannot explain why lAP, which is ubiquitously expressed, was thought to be a carcinoma-specific antigen. Campbell et al. report that mRNA for this protein is present in all normal tissues tested (7) . In our hands (data not shown), as well as for Campbell et al. (7), OVTL3 recognizes IAP on several The experiment shown is representative of at least six repetitions for each antibody. Controls included KGAGDV-beads (a ligand specific for LRI [17] ) and HSA beads. These experiments demonstrate that both C~vB3 and lAP were required for Vn-beads binding by HEL cells. (B) Binding of Fn-beads to HEL cells. These experiments were performed as in A, except that the ligand coating on the bead was Fn and the incubation buffer differed in divalent cation content (see Materials and Methods). The binding of Fn-beads to HEL was dependent on t~5/3t but was independent of IAP. were tested for their binding of Vn-beads in the presence of the same antibodies tested in Fig. 9 . Data are the mean + SD for three independent experiments done in duplicate. Attachment was quantitated as AI (see Materials and Methods). B6HI2, which recognizes only human IAP, completely inhibits Vn-beads binding to 45S cells, even though it does not recognize hamster lAP. different cells, including CHO cells transfeeted with human IAP cDNA. Perhaps the specificity has a quantitative rather than qualitative basis. IAP also is homologous to the expected product of the poxvirus A38L reading frame (1, 12, 37) . Interestingly, the A38L product also has an aminoterminal unpaired cysteine, which could form disulfide bonds with other molecules. However, we have not seen covalent interaction of IAP with itself or with any other proteins. The high degree of conservation of the LAP homologue between Vaccinia and Variola suggests that this protein has an important role in the viral life cycle. Many viral proteins have been shown to influence pathogenesis by mimicking or inhibiting host molecules (13) . The function of this viral protein remains unknown.
The multiple membrane-spanning domains in the carboxy terminus of IAP suggest several testable possible roles for lAP in signal transduction. One possibility is that this region of IAP has a transporter or channel function. In this regard, adhesion of endothelial cells to vitronectin or fibronectin causes an increase in [Ca+2]i (34), which can be blocked by B6H12, but not 2D3, suggesting that IAP is involved in the signaling for Ca ÷2 entry into the ceils (34a). However, as yet, we have no direct experimental data to support the hypothesis that LAP can itself act as a membrane channel.
IAP was defined originally as the target of a monoclonal antibody, B6H12, which inhibited the function of a leukocyte B3-1ike integrin, the LRI. Functional inhibition by B6H12 involved its ability to block ligand binding to LRI (16, 17) . In the current study, we have shown that anti-LAP also can block ligand binding to the much better characterized Vn receptor, txv~3, on HEL cells and to Otv receptors on CHO cells. Moreover, binding of Vn-coated particles to CHO cells transfected with human LAP was completely inhibited by B6H12, which recognizes human but not hamster LAP. This dominant effect of the anti-human IAP mAb is very surprising in view of the presence of non-inhibited hamster LAP on these cells. This would be expected if B6H12-bound IAP binds to the integrin in an inhibitory fashion. B6H12 may stabilize a conformation of human LAP which favors physical and functional association with CHO ctvB3. We have previously shown that lAP is capable of existing in two conformational states with different affinities for B6H12 (30) . Another possibility is that the antibody to lAP might generate a signal inhibitory to otvB3 and LRI ligand binding, independent of its ability to associate with these integrins. This would have to be a very specific negative signal, since binding of Fncoated beads to another integrin on the same ceils is unaffected by B6H12. In addition, kinetic studies of Vn-bead binding to HEL cells indicate that the initial rate of Vn binding is unaffected by B6H12 (Gresham, H. D., unpublished observation). If the antibody were simply activating a negative signal, even one specific for o~B3, this would not be expected. Furthermore, data obtained with PMN show that B6H12 but not 2D3 can stimulate the respiratory burst when adherent to a tissue culture plate and that this respiratory burst is inhibited by anti-LRI mAb and LRI ligands in solution (41) . These data favor the possibility that B6H12 can stabilize a signal transduction complex which contains both LRI and LAP, suggesting a model in which LAP association with integrins is dynamic, possibly affected by integrin ligands or other environmental influences on cell phenotype and by some anti-LAP mAbs. Notably, cytokine receptor complexes often contain a transmembrane protein which is not directly involved in ligand binding but which is critical for high affinity ligand binding and signal transduction (11, 23, 26, 28) . Gpl30 functions in this way as a component of the IL6 and LIF receptors, as does the/3 chain of the IL3, IL5, and GM-CSF receptors (14, 18 23, 28, 38) . In at least one case, that of gp130, ligand is required to stabilize the association of this additional chain with the ligand binding subunit of the IL6 receptor (18, 38) . At this time, the association of gpl30 with the IL6 receptor appears to be a reasonable model for the association of IAP with LRI and t'¢,/~3.
The existence of at least one other immunoglobulin superfamily member which modulates integrin binding of ligands (21) suggests that LAP-like molecules may be a general mechanism involved in integrin dependent signal transduction.
